MUNICH, May 7, 2025 /PRNewswire/ — At EES Europe 2025, one of the leading events for the energy storage industry, Aeson Power debuted its sodium products including the SIBPOM-4850 for telecommunications, the SIBPOM-12100 for UPS, the SIBPOM-125kWh energy storage cabinet for C&I-scale, and the NaForce and NaPulse for passenger cars.

Aeson Power’s sodium products utilize NFPP polyanionic technology battery cells. The products feature intrinsic safety (capacity can be fully restored after discharging to zero volts), excellent high-temperature resistance (cells operate normally at 60 C), superior rate performance, high charge-discharge efficiency (RTE easily exceeds 95%), and long life (over 15,000 cycles).

For the C&I energy storage, Aeson Power launched sodium product SIBPOM-125kWh energy storage cabinet with safety, intelligence, wide temperature range, and high energy density, and has passed strict third-party tests based on lithium battery standards such as IEC 62619 and IEC 62933.

For the vehicle, Aeson Power introduced two series of sodium-ion batteries ─ the NaForce following European standards (EU) and NaPulse following Japanese standards (JIS) ─ each of which includes both a start-stop option and a starting option and provides instant starting at extreme temperatures, fast charging, light weight design and long service life, especially the start-stop batteries, which have a deep cycle capacity of 180,000. They are suitable for passenger cars and the best alternative to AGM and MF batteries.

Along with the sodium product, Aeson Power also displayed the lithium battery energy storage products – a 261kWh C&I energy storage cabinet and a 5MWh containerized energy storage system – certified to IEC standards by TÜV SÜD and French BV and the bipolar lead-acid battery – TRE, TUS, TSS, THS series – with excellent PSoC cycling, better cranking performance, and high power output.

Aeson Power’s general manager Shirley Zhang stated, “Our bipolar lead-acid batteries are globally unique in low temperature of -40C performance, with wide market adoption. Now, our sodium-ion batteries will also achieve breakthroughs. The safety of sodium battery technology is a critical foundation for future applications. Aeson Power will keep focusing R&D resources on sodium technology.”

About Aeson Power

Aeson Power is a trusted Australian provider of reliable energy solutions, including industry-proven batteries and cutting-edge energy storage solutions. Aeson Power has built an innovation ecosystem, spanning material selection, cell design, and system integration and become a pioneer in next-generation energy storage solutions. Visit www.aesonpower.com for more information.

Media Contact

Ivans Xu
ivansxu@aesonpower.com

• Primary Endpoint Met: Statistically significant reduction in heavy menstrual bleeding achieved in all dosage of Merigolix groups compared to placebo
• Broader Therapeutic Potential: Positive Phase 2 results in both uterine fibroids and endometriosis could place Merigolix as a strong best-in-class candidate for novel drug approval and global licensing opportunities
• Multi-Indication Development: Clinical trials are underway for three indications enhancing the asset value-uterine fibroids, endometriosis, and assisted reproductive technology (ART), the latter in collaboration with Hansoh Pharma in China

SEONGNAM, South Korea, May 7, 2025 /PRNewswire/ — TiumBio (KRX: 321550.KQ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable disease, today announced that Merigolix (code name: TU2670, Daewon’s code name: DW4902) has successfully met the primary endpoint of reducing heavy menstrual bleeding in a Phase 2 clinical trial for uterine fibroids. In this trial, Merigolix demonstrated statistically significant improvements across all dosage groups compared to placebo in patients with uterine fibroids.

Merigolix is an investigational, once-daily, oral gonadotropin-releasing hormone (GnRH) receptor antagonist. Unlike traditional GnRH agonists, which require injection and often lead to an initial hormone surge, Merigolix offers a more patient-friendly oral administration without an initial hormonal flare, providing a faster onset of action and improved treatment adherence.

The Phase 2 clinical trial of Merigolix in uterine fibroids was conducted by TiumBio’s partner, Daewon Pharmaceutical, and enrolled a total of 71 women diagnosed with uterine fibroids. Participants were randomly assigned to receive high, medium, or low doses of Merigolix, or placebo, administered orally once daily for 12 weeks, followed by a 12-week observation period. The results showed that Merigolix led to statistically significant improvements in heavy menstrual bleeding (HMB)—a validated clinical endpoint—across all dosage groups compared to the placebo.

In addition to the primary endpoint, Merigolix demonstrated statistically and clinically meaningful improvements in several key secondary endpoints, including fibroid size reduction, increased hemoglobin levels (indicating improved anemia), and relief of pelvic pain. The safety and tolerability profile of Merigolix was consistent with prior clinical data, with no new safety signs.

The mechanism of action of Merigolix can be used in various disorders, including endometriosis, uterine fibroids, ART, precocious puberty, and prostate cancer. Notably, in a separate Phase 2 clinical trial for endometriosis completed in 2024, Merigolix also showed excellent therapeutic efficacy and safety, further reinforcing its potential as a promising new treatment.

“We are very excited that Merigolix has demonstrated excellent therapeutic efficacy not only in endometriosis but also in uterine fibroids,” said Hun-Taek Kim, Ph.D., MBA, CEO of TiumBio. “successfully achieving both efficacy and safety in Phase 2 significantly increases the probability of regulatory approval and licensing opportunities. We plan to accelerate development and expand into the global uterine fibroid treatment market,” he added.

“Uterine fibroids are a condition that causes significant suffering for many women, and we believe Merigolix has the potential to become an important new oral treatment that addresses this unmet medical need,” said Jonathan In Baek, President of Daewon Pharmaceutical. “We are pleased with the positive results in uterine fibroids and will continue our efforts to provide patients with a convenient and effective new treatment option,” he continued.

Uterine fibroids are benign tumors that develop in the uterus, primarily affecting women of reproductive age, particularly those in their 30s and older. The condition has a high prevalence rate of approximately 20% among women over the age of 35. The most common symptom is heavy menstrual bleeding, but it can also cause abnormal uterine bleeding, pelvic pain, and anemia.

Meanwhile, TiumBio entered into a licensing agreement with Daewon Pharmaceutical in 2019, granting Daewon the rights to develop and commercialize Merigolix in South Korea.

About TiumBio Co., Ltd.

TiumBio (KRX: 321550.KQ) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics for patients with rare and incurable diseases. Its mission is to expand the hope and happiness of mankind through our science. TiumBio has three leading pipeline assets: Merigolix (code name: TU2670), TU2218, and TU7710, all in various stages of clinical development.

Merigolix is a once-daily, oral GnRH receptor antagonist being developed for the treatment of endometriosis, uterine fibroids, and assisted reproductive technology. TU2218 is a first-in-class oral immune-oncology therapy targeting TGF-β and VEGF pathways to promote response rates in cancer patients when used in combination with immune checkpoint inhibitors. TU7710 is a novel rFVIIa designed to extend its half-life in order to provide more clinical benefits to hemophilia patients with inhibitors.

With its expertise in drug development, TiumBio is committed to the discovery and development of innovative treatments to ease the burden of debilitating diseases. For further information, visit our website at www.tiumbio.com/en and connect with us on LinkedIn.

Contacts:

Junseok Jang, Head of Corporate Communications & Investor Relations
junseokjang@tiumbio.com

Da-ye Song, Manager, Corporate Communications & Investor Relations
dayesong@tiumbio.com

Leading Online Waiver and Risk Management Data Solutions to Be Offered Exclusively via Expanded  accesso  Ecosystem

TWYFORD, England, May 7, 2025 /PRNewswire/ — accesso Technology Group (AIM: ACSO), the premier technology solutions provider for attractions and venues worldwide, today announced the asset acquisition of 1RISK – a leader in cloud-based online liability waiver and incident risk management data technology for the leisure and recreation industries, with particular strength in the ski sector.

Founded in 2012, 1RISK developed technology to streamline the process of securing liability waivers for activities such as ticket and pass purchases, equipment rentals and lessons. Over the years, the SaaS-based solutions were expanded to include critical risk management tools, such as incident reporting and dispatch operations tracking, allowing operators to leverage data to reduce the frequency and severity of incidents over time.

The 1RISK liability waiver application, 1Waiver, is the market leading solution for ski resorts across North America.  With more than 160 venues across North America – nearly half of which are also accesso clients – the technology enabled the completion of over 4 million waivers in 2024 alone. accesso has long supported integration with 1Waiver across its eCommerce and point-of-sale technologies. Moving forward, the 1RISK range of solutions will be included as part of accesso’s broader suite of offerings and will be made available exclusively to venues utilizing accesso products.

“As the leading provider of commerce solutions for the ski operators across North America, further enhancing the Accesso offering with 1RISK’s proven technology extends our commitment to delivering innovative, comprehensive solutions to the leisure sector,” said Steve Brown, CEO of accesso.

Charles Mickley, founder and CEO of 1RISK, shared: “As a long-standing partner of Accesso, we have seen first-hand their dedication to innovation and guest experience. We are excited to see the range of 1RISK technology become an integral part of Accesso’s powerful ecosystem, helping operators support their overall approach to risk management.”

Following completion of the asset acquisition, staff members from 1RISK will join accesso and continue to support the development of leading-edge risk management technologies tailored for the needs of ski resorts, recreation venues and activity-based destinations worldwide.

About accesso Technology Group plc
accesso is the leading global provider of patented and award-winning technology solutions that redefine the guest experience, drive increased revenue, streamline operations, and support data-driven business decisions for leisure and entertainment operators. Currently serving over 1,200 venues worldwide, accesso invests heavily in research and development to provide venues with technology that empowers unforgettable guest experiences. Staffed by a team of attractions, cultural venue, and ski industry veterans, accesso partners with venues to maximize guest engagement and revenue through intuitive ticketing, point-of-sale, virtual queuing, distribution, and experience management technologies.

accesso is a public company, listed on AIM: a market operated by the London Stock Exchange. Learn more at accesso.com or follow accesso on X (Twitter), LinkedIn and Facebook.

About 1RISK
1RISK technology provides an easy and efficient method of data entry that allows resorts and businesses to track and analyze customer and workplace incidents. The broad range of 1RISK solutions help operators reduce the frequency and severity of incidents while improving operational insights.

HONG KONG, May 7, 2025 /PRNewswire/ — Pharos Network, a high-performance blockchain built for real-world assets (RWAs), announced the launch of its Testnet today. Designed for institutional-grade RWAs and enterprise-scale DeFi, Pharos offers a next-generation, modular infrastructure that addresses the key bottlenecks preventing institutions from entering Web3. The platform powers scalable deployment of decentralized applications, enables efficient payment solutions, and unlocks new use cases for tokenized assets.

The Pharos Testnet achieves up to 30,000 transactions per second with one-second finality, setting a new benchmark for Layer 1 blockchain performance. Its GPU-like architecture could support billions of users and reduce storage usage by 80%. The network also features built-in support for decentralized AI and privacy preserving SPN. With ZK-based KYC/AML capabilities, Pharos ensures enterprise-ready security and compliance. It remains fully EVM-compatible, offering faster and cheaper transactions, while enabling flexible, on-chain innovation.

Pharos’s product stack directly addresses the core bottlenecks in RWA adoption—scalability, compliance, and flexibility—unlocking new use cases across sectors such as renewable energy industry finance, payment, supply chain finance, and tokenized real estate. Its modular, high-throughput infrastructure enables secure deployment of RWA at scale, while meeting the regulatory and performance demands of the financial industry.

A growing ecosystem is already emerging on the Pharos Testnet, enabling innovative Defi use cases for RWAs. As an early collaborator of Pharos, OKX Wallet will support Pharos Testnet natively at launch. Early Pharos ecosystem projects include Zenith Swap, ELFi, Buzzing Club, Nextmate.AI, Faroswap, R2, OpenFi, Hemera, Blocksense, Supra, and more.

Founded by former AntChain and Alibaba blockchain leaders, the Pharos team brings deep enterprise experience, uniquely positioning it to deliver enterprise-grade solutions for institutions exploring green finance, payments, and new forms of programmable ownership and asset tokenization.

“The Pharos Testnet represents a significant milestone in our mission to unlock the true potential of RWAs. By providing a high-performance, scalable, and adaptable platform, Pharos meet the needs of bringing real world assets on a chain and bringing utilities to these assets.” said Alex Zhang, CEO of Pharos Network. “We’re excited to watch innovation flourish on Pharos and accelerate the convergence of traditional finance and decentralized technology.

Developers and users can access and experience the Testnet by visiting testnet.pharosnetwork.xyz.

About Pharos

Pharos Network is a revolutionary Layer 1 blockchain platform that sets new benchmarks in decentralized technology with its extreme performance and scalability. Founded by ex-blockchain leaders from Ant Financial and Alibaba, Pharos aims to build the best chain for RWAs and enterprise-grade DeFi, achieving the highest EVM Layer-1 performance with 50K TPS and being the first to reach 2 gigagas/sec. In addition, Pharos is a co-developer of SmartCogent, an AI toolkit for large language models (LLMs), and the core development team of DTVM technology. For more information, please visit https://pharosnetwork.xyz.

• Tailored luxury: Guests at Atlantis Dubai’s two resorts – Atlantis, The Palm and Atlantis The Royal – can now access premium room upgrades, stay extensions, and experiences with ease.
• Seamless integration: Plusgrade’s enterprise upselling platform integrates with Atlantis Dubai’s systems to automate and personalize upsell offers.
• Proven success: Building on a successful pilot, this partnership sets a new standard for upsell in ultra-luxury hospitality.

MONTREAL, May 7, 2025 /PRNewswire/ — Plusgrade, a global leader in ancillary revenue solutions for the travel industry, is thrilled to announce its partnership with Atlantis Dubai’s two premier luxury resorts: Atlantis, The Palm and Atlantis The Royal. This collaboration introduces an innovative solution that enhances the guest experience by offering seamless access to premium room upgrades, stay extensions, and exclusive experiences, unlocking new revenue opportunities through an intelligent, fully automated, and white-labeled platform.

A Smarter Approach to Personalized Luxury

With this seamless integration, Atlantis Dubai replaces a legacy system with an intuitive, fully automated platform. Now, guests can bid on or purchase upgrades in a way that is effortless, highly personalized, and aligned with the resort’s commitment to world-class hospitality. Beyond premium room upgrades, the platform provides guests with even more opportunities to enhance their stay, offering greater flexibility and choice throughout their journey.

The initiative follows a successful pilot at Atlantis, The Palm, where Plusgrade’s solution increased both guest satisfaction and incremental revenue, reinforcing its value as a strategic hospitality technology partner.

Elevating Every Guest Stay

“The power of bidding technology transforms the way travelers interact with their journey,” said Daniele Carrai, Vice President, Revenue Management, Atlantis Dubai. “Having seen the value of Plusgrade’s solutions during my time in the cruise industry, I am thrilled to bring this level of innovation to Atlantis Dubai. Our ‘innovation partnership’ with Plusgrade allows us to push boundaries and continuously evolve our guest offerings. Their commitment to delivering against our unique needs has made them an invaluable partner as we work together to redefine luxury travel.”

“At Atlantis, our guests expect a level of luxury and personalization that sets new benchmarks in the ultra-luxury market,” said Michael Chatzidakis, Director, Revenue Management, Atlantis Dubai. “The ease of using Plusgrade’s intelligent platform allows us to elevate every aspect of the guest journey, offering tailored services and experiences that make each stay unforgettable.”

Powering the Future of Guest Engagement

“Our partnership with Atlantis Dubai is a perfect example of how technology can enhance the guest experience while driving significant ancillary revenue,” said Ken Harris, Founder and CEO of Plusgrade. “By integrating our intelligent upgrade solution, along with other personalized upsell opportunities, we are giving guests greater choice and flexibility while helping Atlantis Dubai unlock new revenue streams. We are proud to work with these iconic resorts to set a new benchmark for luxury hospitality.”

Key Benefits of the Program

1. Exclusive Upgrades: Guests can bid on or purchase room upgrades, ensuring a tailored and elevated stay.
2. Seamless Experience: Fully integrated with Atlantis Dubai’s brand and booking systems for effortless personalization.
3. Maximized Guest Engagement: A range of upsell opportunities ensures every guest can enhance their stay in a way that suits their needs.

This partnership marks a major step in Atlantis Dubai’s commitment to innovation in hospitality, delivering a more personalized and seamless guest experience. With bidding capabilities now live, guests at Atlantis, The Palm and Atlantis The Royal can instantly access exclusive upgrades and experiences.

About Plusgrade

Plusgrade powers the global travel industry with its portfolio of leading ancillary revenue solutions. Over 250 airline, hospitality, cruise, passenger rail, and financial services companies trust Plusgrade to create new, meaningful revenue streams through incredible customer experiences. As the ancillary revenue powerhouse, Plusgrade has generated billions of dollars in new revenue opportunities across its platform for its partners, while creating enhanced travel experiences for millions of their passengers and guests. Plusgrade was founded in 2009 with headquarters in Montreal and has offices around the world. For more information, visit plusgrade.com.

About Atlantis Dubai

Atlantis Dubai is a world-renowned luxury destination comprised of two iconic resorts, Atlantis, The Palm and Atlantis The Royal, offering unparalleled opulence, adventure, and hospitality. Atlantis, The Palm is the region’s first entertainment resort, home to the world-famous Aquaventure World Waterpark with record-breaking slides, The Lost Chambers Aquarium with over 65,000 marine animals, and a vibrant culinary scene featuring Michelin-starred and celebrity chef restaurants. Atlantis The Royal redefines ultra-luxury with cutting-edge design, offering experiences like sky-high pools, fire-breathing fountains, and the world’s largest collection of celebrity chef restaurants. Recognized as the 9th best resort in the world by The World’s 50 Best Resorts 2024, Atlantis The Royal sets a new benchmark for luxury. From award-winning dining and world-class entertainment to awe-inspiring architecture, Atlantis Dubai is where extraordinary moments come to life.
https://www.atlantis.com/

Media Contact: Carrie Moench, Director, Brand & Communications, Plusgrade, pr@plusgrade.com

NYON, Switzerland, May 7, 2025 /PRNewswire/ — The internet’s reigning feline icon, Choupette, has landed her most unexpected role with luxury’s most polarizing watch brand Hublot. The Swiss watchmaker has tapped fashion’s famously pampered cat to celebrate its 20th anniversary of the iconic Big Bang collection.

Hublot Big Bang 20th Anniversary campaign with Choupette

Known for rewriting the rules of luxury, Hublot is the antithesis of quiet design. It challenges the status quo of watchmaking with bold product design and just like the timepieces themselves, Hublot wearers aren’t afraid to stand out. Two decades ago, the introduction of the Big Bang collection ignited a shift in the industry by daring to fuse unconventional materials and disregard traditional tropes of the category. Hublot and its Big Bang have gone from one showstopper to another, building on a spirit of revolution, audacity and playfulness. With many world-firsts and genre-defying feats, the Big Bang will go down in history as the first truly iconic watch of the 21st century and a beacon of creativity in a field that’s usually confined by history and tradition.

The campaign unveils Hublot’s new tagline – “Own It”. A bold and unapologetic call to action, and an uncompromising mindset. This new mantra captures the authentic, loud, and polarising spirit of the brand. Hublot has chosen the one and only Choupette, who doesn’t have a wrist or know how to tell the time. Choupette, a cultural icon, brings her signature attitude to a campaign that celebrates outrageous confidence and radical individuality that define both her and Hublot.

Julien Tornare, Hublot’s CEO says: “The Big Bang represents a revolution in watchmaking, a perfect union of tradition and modernity. While remaining rooted in the values of luxury watchmaking, such as artisanal quality and attention to detail, Hublot has managed to position the Big Bang as a disruptor within an industry that has traditionally seen little design innovation. This is what sets us apart.”

Captured by visionary photographer Carlijn Jacobs, the campaign unfolds in a series of striking, high fashion visuals interspersed with meme-inspired content. With this, Hublot embraces the new language of luxury on social media, engaging people with storytelling, playfulness and unpredictability. 

From ‘failed’ takes to Choupette’s diva moments, the campaign is far from another polished luxury marketing campaign. Including behind-the-scenes footage it offers a rare, self-aware glimpse into a luxury world that doesn’t take itself too seriously. Putting this low filter lens on high luxury allows Hublot to break the fourth wall and bring its audience into the moment, rather than observe from afar.

The campaign commenced on 1st May where Choupette is modelling the Big Bang 20th Anniversary Red Magic. Throughout the month, the spotlight shifts to two more icons: the striking Big Bang Tourbillon Automatic Yellow Neon Saxem, worn by a chic mysterious lady in a statement faux-fur coat, and the Big Bang 20th Anniversary Titanium Ceramic piece, seen on a powerful athlete unapologetically working out right in a gym locker.

Contact
v.pela@hublot.ch 

Hublot Big Bang 20th Anniversary Red Magic and Choupette